Secondary Myelofibrosis Terminated Phase 1 Trials for Mycophenolate mofetil (DB00688)

IndicationStatusPhase
DBCOND0030964 (Secondary Myelofibrosis)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00376519Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesTreatment